People · Operator
Named in public records as an officer, director or promoter · active 2015–2023 · Pharmaceuticals, Other Health Care, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| MAPS Public Benefit Corp | — | Pharmaceuticals | Series D+ | $215.1M | $2.9B | 2023 |
| BaseHealth, Inc. | — | Other Health Care | Series A | $13.6M | $91.7M | 2017 |
| Triton Algae Innovations, Ltd. | — | Biotechnology | Series A | $5.0M | $180.8M | 2015 |
Jason Pyle at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Jason Pyle on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Babak Yazdani | 1 | 18 |
| Arman Pahlavan | 1 | 12 |
| Mostafa Ronaghi | 1 | 8 |
| Farzad Naimi | 1 | 5 |
| Kazutaka Ohno | 1 | 4 |
| ARMAN NADERSHAHI | 1 | 3 |
| Saeid Akhtari | 1 | 3 |
| Stephen Mayfield | 1 | 2 |
| Nicholas Hofmeister | 1 | 2 |
| Dawn McCollough | 1 | 1 |
| Suprotik Basu | 1 | 1 |
| Gisselle Acevedo | 1 | 1 |
| Daniel Grossman | 1 | 1 |
| Richard Doblin | 1 | 1 |
| James Acer | 1 | 1 |
| Hossein Fakrai-Rad | 1 | 1 |
| David Wellis | 1 | 1 |
| Len Smith | 1 | 1 |
| Daniel Sachs | 1 | 1 |
| Xun Wang | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.